Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.
Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.
SurvivorNet on MSN5d
Over-The-Counter Aspirin and its ‘Practice-Changing’ Impact on Colorectal Cancer — Results from a Remarkable Study that Could Positively Affect ‘More Than a Third of ...A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback